Kura Oncology
KURA
Kura Oncology (KURA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Citizens | Maintained | Market Outperform | $24.00 | Aug 24, 2026 |
| Wedbush | Maintained | Outperform | $38.00 from $36.00 | Aug 13, 2026 |
| Wedbush | Maintained | Outperform | $36.00 | Jul 28, 2026 |
| Citizens | Maintained | Market Outperform | $24.00 | Jun 15, 2026 |
| Lake Street | Initiated Coverage | Buy | $23.00 | Apr 14, 2026 |
| Mizuho | Maintained | Outperform | $25.00 from $30.00 | Mar 24, 2026 |
| UBS | Maintained | Buy | $15.00 from $16.00 | Mar 13, 2026 |
| Wedbush | Maintained | Outperform | $36.00 from $38.00 | Mar 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 | Jan 13, 2026 |
| Leerink Partners | Maintained | Outperform | $20.00 from $25.00 | Jan 13, 2026 |
| Barclays | Maintained | Overweight | $28.00 from $11.00 | Nov 24, 2025 |
| Wedbush | Maintained | Outperform | $38.00 from $36.00 | Nov 14, 2025 |
| UBS | Maintained | Buy | $16.00 from $14.00 | Nov 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 | Oct 20, 2025 |
| JMP Securities | Maintained | Market Outperform | $24.00 | Oct 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 | Sep 30, 2025 |
| Guggenheim | Initiated Coverage | Neutral | — | Sep 4, 2025 |
| JMP Securities | Maintained | Market Outperform | $24.00 from $28.00 | Aug 11, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | — | Jun 26, 2025 |
| Wedbush | Maintained | Outperform | $36.00 | Jun 20, 2025 |
Frequently asked questions
What is the latest analyst rating on KURA?
On Aug 24, 2026, Citizens maintained Kura Oncology at Market Outperform with a price target of $24.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.